Annual CFO
-$70.21 M
-$14.37 M-25.73%
December 31, 2024
Summary
- As of March 12, 2025, AVBP annual cash flow from operations is -$70.21 million, with the most recent change of -$14.37 million (-25.73%) on December 31, 2024.
- AVBP annual CFO is now -60.92% below its all-time high of -$43.63 million, reached on December 31, 2022.
Performance
AVBP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$16.15 M
+$193.00 K+1.18%
December 31, 2024
Summary
- As of March 12, 2025, AVBP quarterly cash flow from operations is -$16.15 million, with the most recent change of +$193.00 thousand (+1.18%) on December 31, 2024.
- Over the past year, AVBP quarterly CFO has increased by +$2.94 million (+15.38%).
- AVBP quarterly CFO is now -87.68% below its all-time high of -$8.61 million, reached on June 1, 2023.
Performance
AVBP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$70.21 M
-$1.24 M-1.80%
December 31, 2024
Summary
- As of March 12, 2025, AVBP TTM cash flow from operations is -$70.21 million, with the most recent change of -$1.24 million (-1.80%) on December 31, 2024.
- Over the past year, AVBP TTM CFO has dropped by -$2.14 million (-3.15%).
- AVBP TTM CFO is now -153.07% below its all-time high of -$27.74 million, reached on September 1, 2022.
Performance
AVBP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AVBP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.7% | +15.4% | -3.1% |
| 3 y3 years | - | +15.4% | -3.1% |
| 5 y5 years | - | +15.4% | -3.1% |
AVBP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.9% | at low | -87.7% | +41.8% | -153.1% | at low |
| 5 y | 5-year | -60.9% | at low | -87.7% | +41.8% | -153.1% | at low |
| alltime | all time | -60.9% | at low | -87.7% | +41.8% | -153.1% | at low |
ArriVent BioPharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$70.21 M(+25.7%) | -$16.15 M(-1.2%) | -$70.21 M(+1.8%) |
| Sep 2024 | - | -$16.34 M(-14.4%) | -$68.97 M(+1.3%) |
| Jun 2024 | - | -$19.09 M(+2.5%) | -$68.07 M(+18.2%) |
| Mar 2024 | - | -$18.63 M(+24.9%) | -$57.59 M(+3.1%) |
| Dec 2023 | -$55.84 M | -$14.91 M(-3.4%) | -$55.84 M(+36.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$15.44 M(+79.4%) | -$40.93 M(-23.1%) |
| Jun 2023 | - | -$8.61 M(-49.0%) | -$53.23 M(+19.3%) |
| Mar 2023 | - | -$16.88 M(-39.2%) | -$44.63 M(+60.8%) |
| Dec 2022 | -$43.63 M | - | - |
| Sep 2022 | - | -$27.74 M | -$27.74 M |
FAQ
- What is ArriVent BioPharma annual cash flow from operations?
- What is the all time high annual CFO for ArriVent BioPharma?
- What is ArriVent BioPharma annual CFO year-on-year change?
- What is ArriVent BioPharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly CFO year-on-year change?
- What is ArriVent BioPharma TTM cash flow from operations?
- What is the all time high TTM CFO for ArriVent BioPharma?
- What is ArriVent BioPharma TTM CFO year-on-year change?
What is ArriVent BioPharma annual cash flow from operations?
The current annual CFO of AVBP is -$70.21 M
What is the all time high annual CFO for ArriVent BioPharma?
ArriVent BioPharma all-time high annual cash flow from operations is -$43.63 M
What is ArriVent BioPharma annual CFO year-on-year change?
Over the past year, AVBP annual cash flow from operations has changed by -$14.37 M (-25.73%)
What is ArriVent BioPharma quarterly cash flow from operations?
The current quarterly CFO of AVBP is -$16.15 M
What is the all time high quarterly CFO for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly cash flow from operations is -$8.61 M
What is ArriVent BioPharma quarterly CFO year-on-year change?
Over the past year, AVBP quarterly cash flow from operations has changed by +$2.94 M (+15.38%)
What is ArriVent BioPharma TTM cash flow from operations?
The current TTM CFO of AVBP is -$70.21 M
What is the all time high TTM CFO for ArriVent BioPharma?
ArriVent BioPharma all-time high TTM cash flow from operations is -$27.74 M
What is ArriVent BioPharma TTM CFO year-on-year change?
Over the past year, AVBP TTM cash flow from operations has changed by -$2.14 M (-3.15%)